Open-angle Glaucoma
Conditions
Keywords
matrix metalloproteinase 13, tissue inhibitor of metalloproteinases 3, calcium-sensing receptor, trabecular meshwork, open-angle glaucoma
Brief summary
This study was to assess the distinct expression of matrix metalloproteinase 13,tissue inhibitor of metalloproteinases 3, and calcium-sensing receptor, in human trabecular meshwork between normal and glaucomatous eyes.The expressions of matrix metalloproteinase 13, tissue inhibitor of metalloproteinases 3 and calcium-sensing receptor in the trabecular meshwork tissues were examined by streptavidin-peroxidase immunohistochemical staining method and western blot, and histological changes of trabecular meshwork were studied by Hematoxylin and Eosin staining.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* intraocular pressure greater than 22 mmHg with two or more medications * wide anterior chamber angle * glaucomatous optic neuropathy (Glaucomatous optic nerve damage was defined as cup-to-disc ratio higher than 0.7 or focal loss of the nerve fiber layer (notch) associated with a consistent glaucomatous visual field defect * visual field loss consistent with optic nerve damage and visual fields were performed by using standard automated perimetry
Exclusion criteria
* the presence of any secondary form of glaucoma including exfoliation syndrome or a history of ocular trauma, etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the expressions of matrix metalloproteinase 13 and calcium-sensing receptor | one hour after operation |
Secondary
| Measure | Time frame |
|---|---|
| histological changes of trabecular meshwork | one hour after operation |
Countries
China